Global IDEA by Hanney, S & Buxton, MJ
technology: access to safe drinking wa-
ter, effective sanitation, safe housing,
adequate nutrition (especially for
women and children) and universal ed-
ucation. Furthermore, local health ser-
vice research in low-income countries
would greatly assist these countries to
expand application of their current ar-
senal of effective health care interven-
tions. Yes, developing countries have
been neglected in terms of biomedical
and clinical research into infectious dis-
eases, but the technical knowledge
needed to improved population health
in developing countries already exists.
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We applaud the recent informal as-sessment of the potential health
and economic benefits that might flow
from an accelerated program of research
to combat global infectious diseases.1
The policies adopted for the organiza-
tion and prioritization of health re-
search should themselves, wherever pos-
sible, be evidence-based.2 However,
many conceptual and empirical obsta-
cles face those attempting retrospective
analyses of economic benefits from spe-
cific programs of health research; in
particular, it is necessary to take full ac-
count of the cost of the contributing re-
search and of its application, and to then
assess the value of the incremental
health and other benefits that follow.3
The proposal from the Global Infec-
tious Disease Evidence and Analyses
(Global IDEA) network1 refers to work
from the United States on the economic
benefits of health research4 that is
rightly receiving considerable attention.
In assessing returns in the context of the
global debate about infectious diseases,
however, one obvious problem is the
value placed on the health gain. The US
study valued the life of a US citizen at
about $3 million but even if that is the
appropriate value to use in the US con-
text, it is improbable that such a figure
would be applied rationally by decision-
makers in other countries.
The Global IDEA Scientific Ad-
visory Committee also argues that if
$2 billion is spent over 10 years for re-
search on new tools that lead to a 5%
increase in lives saved, this could, using
figures from the important report from
the Commission on Macroeconomics
and Health,5 result in annual returns of
about $9 billion. We suggest that, in es-
timating the real return, it is essential to
allow for the (possibly very substantial)
costs of applying any new tools or tech-
nologies that result from the research.3
More work is needed to refine the
methods for analyzing the payback
from investments in health research.
Initiatives such as the program pro-
posed by Global IDEA might then be
supported with firmer evidence of their
possible benefit. 
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[Five members of the Global IDEA
Scientific Advisory Committee
respond to Dr. Moore and colleagues:]
Health determinants are not neces-sarily health interventions. Inter-
ventions need to be practicable (i.e.,
widespread use is possible) and afford-
able. We agree with David Moore and
his colleagues that universal primary
education has social returns beyond its
impact on child and maternal survival.
However, safe housing, sanitation and
food subsidies are more costly and less
practicable than are public health inter-
ventions.1
As we have recently reviewed,2 re-
search and the diffusion of knowledge
have improved public health interven-
tions (which differ from the more nar-
rowly defined “medical” interventions),
making them more efficacious and
cheaper, which means that they are more
cost-effective. Thus, mortality fell more
rapidly in the 20th century than it fell in
the 19th century. Access to vaccination
and treatment of respiratory infections
and diarrhea explain more of the decline
in child mortality in India since 1975
than do differences in income growth or
education.3,4 In rural Senegal, recent
mortality decline can be traced to specific
interventions, even in the absence of uni-
versal safe water, sanitation or housing.5
Smoking controls and changes in satu-
rated fat intake have decreased adult
mortality in Poland.6 (Declines in mortal-
ity due to tuberculosis before 1950 are a
riddle. Although these declines were not
due to antimicrobials, it is unclear if bet-
ter living standards were responsible.
Less well studied cofactors for tuberculo-
sis may well have played a role.7) 
Interventions based on “egalitarian
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